Cierra N. Sharp

Cierra N. Sharp

Jun 14, 2016

Group 6 Copy 14
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    A noninvasive approach to monitor the health of Maine's black bear population

    For over 40 years, state biologists have guided black bear management in Maine using data collected from radio...

    How do chimpanzees adapt to a savanna woodland in Tanzania?

    75% of Tanzania’s chimpanzees live in open “savanna” woodlands. Considered a marginal habitat due to low food...

    Can spiders be used as bioindicators of environmental pollution in a geothermal area?

    Geothermal stations cause emissions of pollutants into the environment and can cause damage to living organisms...

    Backer Badge Funded